google_counter
Treatment of neuroendocrine tumor (NET) of the prostate with chemotherapy (692220) | University Hospital Halle (Saale) - BookingHealth
{"translation_price":"50","translation_doc_price":"40","child_coefficient":"1.1","transfer_price":"2.00","transfer_price_vip":"5.00","constant_transfer_price_vip":350,"constant_transfer_price":150,"constant_transfer_distanse":60,"type":"treatment","program_full_story":"<ul>\n\t<li>Initial presentation in the hospital<\/li>\n\t<li>Clinical history taking<\/li>\n\t<li>Review of medical records<\/li>\n\t<li>Physical examination<\/li>\n\t<li>Laboratory tests:\n\t<ul>\n\t\t<li>complete blood count<\/li>\n\t\t<li>biochemical analysis of blood<\/li>\n\t\t<li>tumor markers<\/li>\n\t\t<li>indicators of inflammation<\/li>\n\t\t<li>coagulation tests<\/li>\n\t<\/ul>\n\t<\/li>\n\t<li>Ultrasound scan of the abdomen<\/li>\n\t<li>Differential diagnosis with other diseases<\/li>\n\t<li>Chemotherapy (1 course)<\/li>\n\t<li>Cost of essential medicines<\/li>\n\t<li>Nursing services<\/li>\n\t<li>Consultation of related specialists (tumor board)<\/li>\n\t<li>Treatment by chief physician and all leading experts<\/li>\n\t<li>Elaboration of further recommendations<\/li>\n<\/ul>\n<div class=\"program_how_program_going mt-4\"><h4>How program is carried out<\/h4><p style=\"text-align:justify\"><strong>During the first visit<\/strong>, the doctor will conduct a clinical examination and go through the results of previous laboratory tests and instrumental examinations. After that, you will undergo an additional examination, including laboratory assessment of liver and kidney function, ultrasound scan. Based on the received results, the doctor will elaborate the chemotherapy regimen. If necessary, related medical specialists will be involved in the elaboration of a treatment regimen (tumor board).<\/p>\n\n<p style=\"text-align:justify\"><strong>Chemotherapy&nbsp;<\/strong>is carried out as the day hospital procedure, without mandatory admission to the hospital. After the placement of a venous catheter, you will stay in a comfortable ward. An infusion system will be connected to the catheter, through which the required drug or a drug combination will be administered. All drugs are administered by intravenous drip, slowly, so the total duration of the infusion can be up to several hours. All this time, doctors and nurses will monitor your health condition closely.<\/p>\n\n<p style=\"text-align:justify\"><strong>After the course of chemotherapy<\/strong>, you will stay under medical supervision in the ward for a few more hours. If your general condition is good, your doctor will allow you to leave the hospital. You will receive the medical report with detailed recommendations regarding further treatment. In the future, you will be able to have a distant consultation with your attending physician and schedule the next course of chemotherapy, if necessary.<\/p>\n<\/div><div class=\"program_required_documents mt-4\"><h4>Required documents<\/h4><ul>\n\t<li style=\"text-align: justify;\">Medical records<\/li>\n\t<li style=\"text-align: justify;\">MRI\/CT scan (not older than 3 months)<\/li>\n\t<li style=\"text-align: justify;\">Biopsy results (if available)<\/li>\n<\/ul>\n<\/div>","program_full_story_crm":"<ul>\n\t<li>Initial presentation in the hospital<\/li>\n\t<li>Clinical history taking<\/li>\n\t<li>Review of medical records<\/li>\n\t<li>Physical examination<\/li>\n\t<li>Laboratory tests:\n\t<ul>\n\t\t<li>complete blood count<\/li>\n\t\t<li>biochemical analysis of blood<\/li>\n\t\t<li>tumor markers<\/li>\n\t\t<li>indicators of inflammation<\/li>\n\t\t<li>coagulation tests<\/li>\n\t<\/ul>\n\t<\/li>\n\t<li>Ultrasound scan of the abdomen<\/li>\n\t<li>Differential diagnosis with other diseases<\/li>\n\t<li>Chemotherapy (1 course)<\/li>\n\t<li>Cost of essential medicines<\/li>\n\t<li>Nursing services<\/li>\n\t<li>Consultation of related specialists (tumor board)<\/li>\n\t<li>Treatment by chief physician and all leading experts<\/li>\n\t<li>Elaboration of further recommendations<\/li>\n<\/ul>\n<div class=\"program_how_program_going mt-4\"><h4>How program is carried out<\/h4><p style=\"text-align:justify\"><strong>During the first visit<\/strong>, the doctor will conduct a clinical examination and go through the results of previous laboratory tests and instrumental examinations. After that, you will undergo an additional examination, including laboratory assessment of liver and kidney function, ultrasound scan. Based on the received results, the doctor will elaborate the chemotherapy regimen. If necessary, related medical specialists will be involved in the elaboration of a treatment regimen (tumor board).<\/p>\n\n<p style=\"text-align:justify\"><strong>Chemotherapy&nbsp;<\/strong>is carried out as the day hospital procedure, without mandatory admission to the hospital. After the placement of a venous catheter, you will stay in a comfortable ward. An infusion system will be connected to the catheter, through which the required drug or a drug combination will be administered. All drugs are administered by intravenous drip, slowly, so the total duration of the infusion can be up to several hours. All this time, doctors and nurses will monitor your health condition closely.<\/p>\n\n<p style=\"text-align:justify\"><strong>After the course of chemotherapy<\/strong>, you will stay under medical supervision in the ward for a few more hours. If your general condition is good, your doctor will allow you to leave the hospital. You will receive the medical report with detailed recommendations regarding further treatment. In the future, you will be able to have a distant consultation with your attending physician and schedule the next course of chemotherapy, if necessary.<\/p>\n<\/div>","is_ambulant":"1","bh_fee":"0","only_for_children":"0","no_service":"0","with_prepayment":"1","show_calculator":"1","paket_type":"1","btn_type":"0","clinic_icon":"60004168eda58.jpg","city":"Halle","clinic_site":"http:\/\/www.medizin.uni-halle.de\/index.php?id=788","department_recommend":"1","country":"Germany","country_id":"1","clinic_name":"University Hospital Halle (Saale)","cinic_name":"University Hospital Halle (Saale)","department_id":"1449","duration":"5","direction":"Cancer","min_duration":0,"clinic_id":"853","paketPrice":3200,"paket":"<ul>\n <li> Interpreter up to 8 hours<\/li>\n <li>Translation of up to 5 pages<\/li>\n <li>Visa support<\/li>\n\n<\/ul>","title":"Treatment of neuroendocrine tumor (NET) of the prostate with chemotherapy","price":{"val":7566.01,"type":"val"},"price_surcharge":0,"price_surcharge_clear":0,"extra_service_clinic":[],"extra_service":[],"translation_hours":"0","translation_doc_count":null,"roads":[{"id":"20","distance":"31","airport_title":"Leipzig"},{"id":"21","distance":"152","airport_title":"Dresden"},{"id":"8","distance":"169","airport_title":"Berlin"}],"pakets":[],"lang":{"day":"Day","days":"days","ambulatory":"Outpatient","stationaryProgram":"Inpatient"}}

Treatment of neuroendocrine tumor (NET) of the prostate with chemotherapy in University Hospital Halle (Saale)

University Hospital Halle (Saale)

Halle, Germany
Program id # 692220
Doctor photo
Prof. Dr. med. Mascha Binder
Department of Hematology and Oncology
Specialized in: hematology, oncology

The program includes:

  • Initial presentation in the hospital
  • Clinical history taking
  • Review of medical records
  • Physical examination
  • Laboratory tests:
    • complete blood count
    • biochemical analysis of blood
    • tumor markers
    • indicators of inflammation
    • coagulation tests
  • Ultrasound scan of the abdomen
  • Differential diagnosis with other diseases
  • Chemotherapy (1 course)
  • Cost of essential medicines
  • Nursing services
  • Consultation of related specialists (tumor board)
  • Treatment by chief physician and all leading experts
  • Elaboration of further recommendations

How program is carried out

During the first visit, the doctor will conduct a clinical examination and go through the results of previous laboratory tests and instrumental examinations. After that, you will undergo an additional examination, including laboratory assessment of liver and kidney function, ultrasound scan. Based on the received results, the doctor will elaborate the chemotherapy regimen. If necessary, related medical specialists will be involved in the elaboration of a treatment regimen (tumor board).

Chemotherapy is carried out as the day hospital procedure, without mandatory admission to the hospital. After the placement of a venous catheter, you will stay in a comfortable ward. An infusion system will be connected to the catheter, through which the required drug or a drug combination will be administered. All drugs are administered by intravenous drip, slowly, so the total duration of the infusion can be up to several hours. All this time, doctors and nurses will monitor your health condition closely.

After the course of chemotherapy, you will stay under medical supervision in the ward for a few more hours. If your general condition is good, your doctor will allow you to leave the hospital. You will receive the medical report with detailed recommendations regarding further treatment. In the future, you will be able to have a distant consultation with your attending physician and schedule the next course of chemotherapy, if necessary.

Required documents

  • Medical records
  • MRI/CT scan (not older than 3 months)
  • Biopsy results (if available)

Service

Price from:
Type of program :
Price for 1 day:
Expected duration of the program:
The minimum duration of the program:
Select

You may also book:

Hospital directly:
Saving:
Guarantee BookingHealth Price from:

About the department

According to the Focus magazine, the Department of Hematology and Oncology at the University Hospital Halle (Saale) ranks among the top German medical facilities specializing in bowel cancer treatment!

The department offers the full range of specialized diagnostics, treatment and follow-up care for patients with oncological diseases and blood diseases. The department's doctors have in their arsenal many innovative effective methods to fight against cancer. In addition, a number of clinical trials are carried out here in order to develop the very latest targeted drugs, immunotherapy drugs, etc. All the department's specialists regularly undergo advanced training courses, which help them to keep abreast of innovations in medicine and to guarantee the best therapy result for patients. The Chief Physician of the department is Prof. Dr. med. Mascha Binder.

The key focus of the department is hematology. The specialists in this field have excellent qualifications in the diagnostics and treatment of benign and malignant blood diseases, as well as diseases of the hematopoietic system. The focus is on acute and chronic types of blood cancer, myeloproliferative and myelodysplastic diseases, lymphomas and multiple myeloma. The therapeutic spectrum includes various types of chemotherapy, targeted drugs, etc. The patients with end-stage pathology are offered treatment within the framework of clinical trials, which in some cases saves or significantly prolongs their life.

The department houses a specialized Bone Marrow Transplant Center. Bone marrow transplantation is one of the most effective methods for the treatment of blood diseases and cancer, especially leukemias and lymphomas. The center has been conducting successful clinical activities for over 10 years and is one of the most modern medical facilities of its kind in Germany.

The department's oncologists provide the diagnostics and treatment of malignant diseases using chemotherapy, immunotherapy, as well as targeted therapy with antibodies or tyrosine kinase inhibitors. The type of therapy or a combination of several types of treatment is selected individually for each patient. An integral part of the treatment is also professional psycho-oncological care. This implies conversations with doctors, which allow the patient to cheer up for an effective treatment while maintaining a positive attitude.

The service range of the department includes:

  • Diagnostics and treatment of benign and malignant diseases of blood, hematopoietic system
    • Acute and chronic types of blood cancer
    • Myeloproliferative diseases
    • Myelodysplastic syndromes
    • Lymphoma
    • Multiple myeloma
  • Diagnostics and treatment of malignant solid tumors
    • Gastrointestinal tumors
    • Head and neck tumors
    • Sarcomas
  • Diagnostics and treatment of blood-clotting disorders (hemostaseology)
    • Hemophilia A and B
    • Von Willebrand disease
    • Rare forms of coagulation factor deficiency and platelet dysfunction (thrombocytopathy)
  • Treatment of complications of oncological diseases and medical care in side effects of treatment
  • Diagnostics and treatment of other diseases

Curriculum vitae

​Prof. Dr. med. Mascha Binder is a therapist specializing in hematology and oncology. Of particular interest to her is immunotherapy in the treatment of cancers, as well as research on the treatment of lymphoid neoplasia. She began her professional training at the University Hospital Freiburg and also worked at the University Hospital Hamburg-Eppendorf for more than 10 years. In the last hospital, she was the Deputy Head of the department and significantly contributed to the expansion of the Comprehensive Cancer Center. Since October 2018, she heads the Department of Hematology and Oncology at the University Hospital Halle (Saale).

Positions in the Department of Hematology and Oncology

  • Head of the department.
  • Head of the Scientific Working Group on Cancer Immunology.

Clinical Focuses

  • Lymphatic neoplasias and multiple myeloma.
  • Benign hematological diseases.
  • Clinical trials.

Research Focuses

  • Translational researches in cancer immunotherapy.
  • B-cell neoplasms: biology and targeted therapy.
  • Resistance mechanisms and their overcoming in the treatment of solid tumors.

Professional Сareer and Honors

  • Since October 2018 Head of the Department of Hematology and Oncology at the University Hospital Halle (Saale).
  • 2018 Cancer Research Prize of the Hamburg Cancer Society.
  • 2016 Digital Leader Award for outstanding achievements in digital information processing at the enterprises.
  • 2015 - 2018 Deputy Head of the Department of Hematology and Oncology at the University Hospital Hamburg-Eppendorf.
  • 2014 Invitation to the position of W2 Professor in Cancer Research and Immunotherapy.
  • 2014 Secretary of the Scientific Congress at the Annual Meeting of the German Society of Hematology and Medical Oncology in Hamburg (more than 6,000 participants).
  • 2013 Senior Physician in the Department of Hematology and Oncology with the Section of Pulmonology at the University Hospital Hamburg-Eppendorf.
  • 2012 Board certification in Hematology and Oncology, habilitation.
  • 2011 Board certification in Internal Medicine, Hubertus Wald Prize for Young Scientists for Cancer Research.
  • 2010 Young Master Prize of the German Society of Hematology and Medical Oncology (DGHO).
  • 2008 - 2018 Department of Hematology and Oncology with the Section of Pulmonology at the University Hospital Hamburg-Eppendorf.
  • 2006 Paul Basset Prize of the European Cancer Center.
  • 2005 - 2007 Department of Hematology and Oncology at the University Hospital Freiburg.
  • 2004 Doctoral degree.
  • 1998 - 2000 Study of Human Medicine in Würzburg, Freiburg, Rome, as well as clinical practice in France, Switzerland, Italy, Australia and the USA.

Photo of the doctor: (c) Universitätsklinikum Halle (Saale) 


About hospital

According to the prestigious Focus magazine, the University Hospital Halle (Saale) ranks among the top German medical facilities!

The history of the hospital has more than 300 years, and during this time it managed to earn an excellent reputation not only in Germany, but throughout the world. The hospital positions itself as a specialized medical facility for the treatment of very severe and rare diseases and injuries. It provides medical care for patients of all age groups in accordance with the very latest scientific achievements. It is worth noting that the hospital is characterized by its successful research activities, especially in the field of cardiovascular diseases and oncopathology. The specialists of these fields have made a significant contribution to the development of new diagnostic methods and therapeutic approaches.

The hospital diagnoses and treats more than 40,000 inpatients and about 120,000 outpatients every year. Such a large number of patients indicates the reliability and effectiveness of medical services.

Some structural units of the hospital deserve special attention. For example, the Central Department of Emergency Medical Care (the largest in Saxony-Anhalt), modern dental rooms, the Perinatal Center and the Transplant Center with a history of more than 40 years.

Thanks to the use of the cutting-edge medical technology and the availability of advanced equipment, many operations and procedures, which previously could entail a lot of risks and consequences, are currently performed in the hospital with the help of sparing techniques. In this context, it is worth noting hybrid heart interventions, robotic interventions in urology (da Vinci surgical system), etc.

In addition, the key to successful clinical practice is the availability in the hospital of experienced and competent medical staff. The total number of medical staff includes more than 4,000 medical employees. Many doctors are known far beyond the borders of Germany, they regularly carry out significant researches, which allow them to develop modern medicine. In addition, the hospital specializes in training of medical students, therefore the qualified doctors and professors are willing to pass on their experience to the younger generation.

Photo: (c) depositphotos

Accommodation in hospital

Patients rooms

The patients of the University Hospital Halle (Saale) live in comfortable single, double and triple patient rooms made in a modern design. All patient rooms are equipped with an ensuite bath with toilet and shower. The standard room includes a comfortable, automatically adjustable bed, a bedside table, a wardrobe, a table and chairs for receiving visitors and a TV. There is access to Wi-Fi. For security reasons, in some places, including in Intensive Care Units, it is forbidden to use laptops and mobile phones. In addition, the hospital offers enhanced-comfort patient rooms.

Meals and Menus

The patient and his accompanying person have a daily choice of three menus. If for any reason you do not eat all the food, you will be offered an individual menu. Please inform the medical staff about your dietary preferences prior to the treatment. Children are offered a special menu with healthy and tasty dishes, rich in nutrients necessary for the growing body.

Further details

Standard rooms include:

Toilet
Shower
Wi-Fi
TV

Religion

Religious services are available upon request.

Accompanying person

During the inpatient program, an accompanying person may stay with you in a patient room or hotel of your choice.

Hotel

During the outpatient program, you may stay in a hotel of your choice. Managers will help you choose the most suitable options.